Los Angeles, CANCT05361941Now EnrollingIRB Ready

Periprosthetic Joint Infections Clinical Trial in Los Angeles, CA

Access cutting-edge periprosthetic joint infections treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by Elute, Inc.

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access periprosthetic joint infections specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related periprosthetic joint infections treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this periprosthetic joint infections clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Periprosthetic Joint Infections Study in Los Angeles

This is a pivotal, prospective, multi-center, randomized, concurrent control, patient and assessor-blinded study with two arms: a treatment arm (where subjects will be treated with the EP Granules with Tobramycin investigational device in the 1st stage of a staged revision for periprosthetic joint infection (PJIs), and a control arm (where subjects are treated with the standard-of-care revision for infected PJIs).

Sponsor: Elute, Inc.

Who Can Participate

Inclusion Criteria

Ages and sexes eligible: at least 22 years, male and female
Candidates with known infected TKA
Life expectancy of at least 1 year
Patient is willing to provide informed consent, is geographically stable and able to comply with the required follow up visits, testing schedule and medication regimen
Adequate soft tissue coverage
Signed institutional review board approved informed consent

Exclusion Criteria

Severe renal impairment with eGFR \<50 ml/min/1.73 m2, or being treated with dialysis
Known hypersensitivity to aminoglycoside antibiotics, or calcium hydroxyapatite
Pre-existing calcium metabolism disorder
Uncontrolled diabetes mellitus (hemoglobin A1c levels \> 8)
A current endocrine or metabolic disorder known to affect osteogenesis (e.g., Paget's disease, renal osteodystrophy, hyperthyroid parathyroid hormone disorder, Ehler- Danlos syndrome, osteogenesis imperfecta)
Neuromuscular disorders such as myasthenia gravis
Untreated malignant neoplasm(s), or currently undergoing radiation chemotherapy
Inadequate neurovascular status in the involved limb that may jeopardize healing
Adult patients requiring a legal guardian to sign informed consent form

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT05361941) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Periprosthetic Joint Infections Treatment Options in Los Angeles, CA

If you're searching for periprosthetic joint infections treatment options in Los Angeles, CA, this clinical trial (NCT05361941) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced periprosthetic joint infections specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all periprosthetic joint infections clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Los Angeles, CA

See all pulmonary embolism clinical trials recruiting in Los Angeles — not just this study.

Browse Pulmonary Embolism Trials in Los Angeles

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA